Improving the quality of life for COPD sufferers
Glyconics is a Cambridge-based start-up company that specialises in point-of-care testing to improve efficiency in health care. Glyconics is an innovative leader in the field, that uses infrared spectroscopy to analyse samples for markers of disease for a wide range of conditions. Glyconics will be the world’s first to produce hand-held infrared devices for chronic obstructive pulmonary disease (COPD) patients. Currently there is no device to detect symptoms of a acute COPD that can escalate to a hospital admission.
Dr Berwyn Clarke Chairman of Glyconics and CEO of PBD Biotech Ltd
To find out more about Biosensors and Diagnostics click to read the GoBio report below.